inTandem1 and inTandem2: increased time in range with sotagliflozin as adjunct therapy to insulin in adults with type 1 diabetes by 24-week continuous glucose monitoring

被引：0

作者：

Danne, T. ^{[1
]}

Cariou, B. ^{[2
]}

Buse, J. B. ^{[3
]}

Garg, S. K. ^{[4
]}

Rosenstock, J. ^{[5
]}

Banks, P. ^{[6
]}

Kushner, J. A. ^{[7
,8
]}

McGuire, D. K. ^{[9
]}

Peters, A. L. ^{[10
]}

Sawhney, S. ^{[6
]}

Strumph, P. ^{[6
]}

机构：

[1] Hannover Med Sch, Dept Diabet Endocrinol & Clin Res, Hannover, Germany

[2] CHU Nantes, Dept Endocrinol, Nantes, France

[3] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA

[4] Univ Colorado Denver, Dept Med & Pediat, Aurora, CO USA

[5] Dallas Diabet Res Ctr Med City, Dallas, TX USA

[6] Lexicon Pharmaceut Inc, The Woodlands, TX USA

[7] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

[8] Texas Childrens Hosp, Houston, TX 77030 USA

[9] Univ Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA

[10] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA

来源：

DIABETOLOGIA | 2018年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

610

引用

下载

页码：S295 / S295

页数：1

共 50 条

[1] INCREASED TIME IN RANGE WITH SOTAGLIFLOZIN AS ADJUNCT THERAPY TO INSULIN IN ADULTS WITH TYPE 1 DIABETES DEMONSTRATED BY 24-WEEK CONTINUOUS GLUCOSE MONITORING (INTANDEM1, INTANDEM2)
Danne, T.
Cariou, B.
Buse, J. B.
Garg, S.
Rosenstock, J.
Banks, P. L.
Kushner, J. A.
McGuire, D. K.
Peters, A. L.
Sawhney, S.
Strumph, P.
DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A140 - A141
[2] Increased Time-in-Range with Sotagliflozin as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes as Demonstrated by 24-Week Continuous Glucose Monitoring (inTandem1, inTandem2)
Danne, Thomas
Cariou, Bertrand
Buse, John B.
Garg, Satish K.
Rosenstock, Julio
Banks, Phillip L.
Kushner, Jake A.
Mcguire, Darren K.
Peters, Anne L.
Sawhney, Sangeeta
Strumph, Paul
DIABETES, 2018, 67
[3] Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2
Rodbard, Helena W.
Giaccari, Andrea
Cariou, Bertrand
Garg, Satish
Davies, Michael J.
Seth, Kiernan
Sawhney, Sangeeta
DIABETES & VASCULAR DISEASE RESEARCH, 2021, 18 (01):
[4] 24-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes (inTandem1)
Buse, J. B.
Garg, S.
Rosenstock, J.
Banks, P.
Sawhney, S.
Strumph, P.
DIABETOLOGIA, 2017, 60 : S410 - S410
[5] 24-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes (inTandem2)
Danne, T.
Cariou, B.
Banks, P.
Sawhney, S.
Strumph, P.
DIABETOLOGIA, 2017, 60 : S87 - S87
[6] 24-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes (inTandem2)
Danne, Thomas
Cariou, Bertrand
Banks, Phillip
Sawhney, Sangeeta
Strumph, Paul
DIABETES, 2017, 66 : LB38 - LB39
[7] Week 24 efficacy and safety of sotagliflozin, a dual sodium-glucose co-transporter-1 (SGLT-1) and SGLT-2 inhibitor, as adjunct therapy to insulin in Type 1 diabetes (inTandem1 and inTandem2 trials)
Danne, T.
Buse, J. B.
Cariou, B.
Garg, S. K.
Rosenstock, J.
Banks, P.
Sawhney, S.
Strumph, P.
DIABETIC MEDICINE, 2018, 35 : 197 - 197
[8] Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Danne, Thomas
Cariou, Bertrand
Buse, John B.
Garg, Satish K.
Rosenstock, Julio
Banks, Phillip
Kushner, Jake A.
McGuire, Darren K.
Peters, Anne L.
Sawhney, Sangeeta
Strumph, Paul
DIABETES CARE, 2019, 42 (05) : 919 - 930
[9] 24-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes (inTandem2; NCT02421510)
Danne, Thomas
Cariou, Bertrand
Sawhney, Sangeeta
Paul, Strumph
INTERNIST, 2018, 59 : S47 - S47
[10] Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
Buse, John B.
Garg, Satish K.
Rosenstock, Julio
Bailey, Timothy S.
Banks, Phillip
Bode, Bruce W.
Danne, Thomas
Kushner, Jake A.
Lane, Wendy S.
Lapuerta, Pablo
McGuire, Darren K.
Peters, Anne L.
Reed, John
Sawhney, Sangeeta
Strumph, Paul
DIABETES CARE, 2018, 41 (09) : 1970 - 1980

← 1 2 3 4 5 →